A detailed history of Ameriprise Financial Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Ameriprise Financial Inc holds 20,067,263 shares of BMY stock, worth $1.18 Billion. This represents 0.27% of its overall portfolio holdings.

Number of Shares
20,067,263
Previous 17,663,295 13.61%
Holding current value
$1.18 Billion
Previous $734 Million 41.57%
% of portfolio
0.27%
Previous 0.2%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$39.66 - $51.75 $95.3 Million - $124 Million
2,403,968 Added 13.61%
20,067,263 $1.04 Billion
Q2 2024

Aug 14, 2024

SELL
$40.25 - $52.99 $84.5 Million - $111 Million
-2,100,379 Reduced 10.63%
17,663,295 $734 Million
Q1 2024

May 15, 2024

SELL
$47.98 - $54.4 $383 Million - $434 Million
-7,980,437 Reduced 28.76%
19,763,674 $1.07 Billion
Q4 2023

Feb 14, 2024

BUY
$48.48 - $57.85 $96.1 Million - $115 Million
1,982,050 Added 7.69%
27,744,111 $1.42 Billion
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $56.5 Million - $63.2 Million
-976,093 Reduced 3.65%
25,762,061 $1.5 Billion
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $41.7 Million - $46.3 Million
653,888 Added 2.51%
26,738,154 $1.71 Billion
Q1 2023

May 15, 2023

BUY
$65.71 - $74.53 $160 Million - $182 Million
2,439,814 Added 10.32%
26,084,266 $1.81 Billion
Q4 2022

Feb 14, 2023

SELL
$68.48 - $81.09 $68.3 Million - $80.8 Million
-996,976 Reduced 4.05%
23,644,452 $1.7 Billion
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $56,745 - $33.5 Million
-436,501 Reduced 1.74%
24,641,428 $1.76 Billion
Q2 2022

Aug 15, 2022

SELL
$72.62 - $79.98 $127 Million - $140 Million
-1,750,042 Reduced 6.52%
25,077,929 $1.93 Billion
Q1 2022

May 16, 2022

SELL
$61.48 - $73.72 $71 Million - $85.1 Million
-1,154,799 Reduced 4.13%
26,827,971 $1.95 Billion
Q4 2021

Feb 14, 2022

SELL
$53.63 - $62.52 $27.3 Million - $31.8 Million
-508,261 Reduced 1.78%
27,982,770 $1.73 Billion
Q3 2021

Nov 15, 2021

SELL
$59.17 - $69.31 $102 Million - $120 Million
-1,724,907 Reduced 5.71%
28,491,031 $1.69 Billion
Q2 2021

Aug 16, 2021

SELL
$61.91 - $67.42 $2.25 Million - $2.45 Million
-36,343 Reduced 0.12%
30,215,938 $2.02 Billion
Q1 2021

May 17, 2021

BUY
$59.34 - $66.74 $88.9 Million - $100 Million
1,498,152 Added 5.21%
30,252,281 $1.91 Billion
Q4 2020

Feb 12, 2021

SELL
$57.74 - $65.43 $37 Million - $41.9 Million
-640,901 Reduced 2.18%
28,754,129 $1.78 Billion
Q3 2020

Nov 16, 2020

SELL
$57.43 - $63.64 $122 Million - $135 Million
-2,128,869 Reduced 6.75%
29,395,030 $1.77 Billion
Q2 2020

Aug 14, 2020

BUY
$54.82 - $64.09 $74.8 Million - $87.4 Million
1,363,804 Added 4.52%
31,523,899 $1.85 Billion
Q1 2020

May 15, 2020

SELL
$46.4 - $67.43 $139 Million - $203 Million
-3,004,927 Reduced 9.06%
30,160,095 $1.68 Billion
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $94.2 Million - $123 Million
1,914,708 Added 6.13%
33,165,022 $2.13 Billion
Q3 2019

Nov 14, 2019

BUY
$42.77 - $50.71 $198 Million - $234 Million
4,624,215 Added 17.37%
31,250,314 $1.59 Billion
Q2 2019

Aug 14, 2019

SELL
$44.62 - $49.34 $73.4 Million - $81.2 Million
-1,645,847 Reduced 5.82%
26,626,099 $1.21 Billion
Q1 2019

May 15, 2019

BUY
$45.12 - $53.8 $65.2 Million - $77.7 Million
1,444,285 Added 5.38%
28,271,946 $1.35 Billion
Q4 2018

Feb 14, 2019

BUY
$48.76 - $63.23 $138 Million - $179 Million
2,827,484 Added 11.78%
26,827,661 $1.39 Billion
Q3 2018

Nov 14, 2018

SELL
$55.19 - $62.25 $4.23 Million - $4.77 Million
-76,598 Reduced 0.32%
24,000,177 $1.56 Billion
Q2 2018

Aug 14, 2018

BUY
$50.53 - $62.98 $420 Million - $523 Million
8,303,421 Added 52.64%
24,076,775 $1.33 Billion
Q1 2018

May 15, 2018

BUY
$59.92 - $68.98 $183 Million - $211 Million
3,061,221 Added 24.08%
15,773,354 $998 Million
Q4 2017

Feb 12, 2018

SELL
$59.94 - $65.35 $115 Million - $125 Million
-1,918,062 Reduced 13.11%
12,712,133 $780 Million
Q3 2017

Nov 07, 2017

BUY
$55.23 - $63.74 $808 Million - $933 Million
14,630,195
14,630,195 $933 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.